Building on this foundation, our study incorporates 3.0T HR-MRI, ultrasound imaging, and GATA3 protein expression to further extend the scope of multidimensional assessment in breast cancer, particularly in tumor detection and prognostic stratification. The gene discussed is GATA3; the disease is breast cancer.